A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...
The Global Acinetobacter Pneumonia Therapeutics Market is valued at approximately USD 300.81 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of over 6.40% from 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback